|
|
|
Insider
Information: |
Parschauer Karah Herdman |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
105,047 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,385,943 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
105,047 |
|
|
Total
Value |
$3,385,943 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
12
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-100.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
67,340 |
2016-06-20 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
Director |
2024-02-07 |
37,707 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2016-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
9,500 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2017-06-20 |
4 |
D |
$63.38 |
$44,683 |
D/D |
(705) |
8,795 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
16,295 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-03-01 |
4 |
D |
$48.43 |
$9,928 |
D/D |
(205) |
16,090 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,431 |
17,521 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-05-10 |
4 |
AS |
$60.00 |
$87,900 |
D/D |
(1,465) |
16,056 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-06-20 |
4 |
D |
$85.31 |
$55,366 |
D/D |
(649) |
15,407 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-06-21 |
4 |
AS |
$82.77 |
$101,476 |
D/D |
(1,226) |
14,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4 |
S |
$78.53 |
$392,650 |
D/D |
(5,000) |
9,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4/A |
OE |
$54.50 |
$272,500 |
D/D |
5,000 |
19,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4/A |
S |
$78.53 |
$392,650 |
D/D |
(5,000) |
14,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
21,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-03-01 |
4 |
D |
$67.55 |
$58,093 |
D/D |
(860) |
20,321 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
7,000 |
21,182 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-03-05 |
4/A |
S |
$65.52 |
$58,051 |
D/D |
(886) |
20,296 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-04-19 |
4 |
D |
$64.43 |
$15,979 |
D/D |
(248) |
20,048 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-04-29 |
4 |
AS |
$68.30 |
$31,964 |
D/D |
(468) |
19,580 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
21,014 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-06-20 |
4 |
D |
$63.48 |
$41,199 |
D/D |
(649) |
20,365 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-06-21 |
4 |
AS |
$63.01 |
$93,822 |
D/D |
(1,489) |
18,876 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-06-24 |
4 |
AS |
$61.50 |
$75,399 |
D/D |
(1,226) |
17,650 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
19,084 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2020-03-01 |
4 |
D |
$56.08 |
$118,777 |
D/D |
(2,118) |
30,400 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,434 |
32,518 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|